{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:00:33Z","timestamp":1792202433560,"version":"4.4.0"},"reference-count":8,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,24]]},"DOI":"10.1182\/bloodadvances.2025018364","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:56:48Z","timestamp":1768337808000},"page":"1964-1966","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Initial low and moderate dose of hydroxyurea has a durable impact on primary stroke prevention in low-income settings"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5567-9629","authenticated-orcid":false,"given":"Shehu U.","family":"Abdullahi","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Bayero University and Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6853-5023","authenticated-orcid":false,"given":"Najibah A.","family":"Galadanci","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-4548","authenticated-orcid":false,"given":"Halima","family":"Bello-Manga","sequence":"additional","affiliation":[{"name":"3Department of Hematology and Blood Transfusion, Kaduna State University\/Barau Dikko Teaching Hospital, Kaduna, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0742-3123","authenticated-orcid":false,"given":"Umma A.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Bayero University and Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binta W.","family":"Jibir","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, Murtala Muhammad Specialist Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkadir H.","family":"Yusuf","sequence":"additional","affiliation":[{"name":"5Department of Administration, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4724-3992","authenticated-orcid":false,"given":"Jamil A.","family":"Galadanci","sequence":"additional","affiliation":[{"name":"6Department of Computer Science, Bayero University, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7258-0073","authenticated-orcid":false,"given":"Mark","family":"Rodeghier","sequence":"additional","affiliation":[{"name":"7Rodeghier Consultants, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-1604","authenticated-orcid":false,"given":"Michael R.","family":"DeBaun","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"1","key":"2026032014065401000_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"2026032014065401000_bib2","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S2352-3026(21)00368-9","article-title":"Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial","volume":"9","author":"Abdullahi","year":"2022","journal-title":"Lancet Haematol"},{"issue":"9","key":"2026032014065401000_bib3","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1002\/ajh.25900","article-title":"Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial","volume":"95","author":"Galadanci","year":"2020","journal-title":"Am J Hematol"},{"issue":"1-2","key":"2026032014065401000_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000073977","article-title":"Validity and reliability of the 'Ten Questions' questionnaire for detecting moderate to severe neurological impairment in children aged 6-9 years in rural Kenya","volume":"23","author":"Mung'ala-Odera","year":"2004","journal-title":"Neuroepidemiology"},{"key":"2026032014065401000_bib5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012544","article-title":"Primary and secondary stroke prophylaxis in children with sickle cell anemia: a meta-analysis","author":"Rangarajan","year":"10  2025","journal-title":"Blood Adv"},{"issue":"11","key":"2026032014065401000_bib6","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.1002\/ajh.25616","article-title":"Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria","volume":"94","author":"Galadanci","year":"2019","journal-title":"Am J Hematol"},{"key":"2026032014065401000_bib7","doi-asserted-by":"crossref","first-page":"h2147","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose","volume":"350","author":"Loudon","year":"2015","journal-title":"Bmj"},{"key":"2026032014065401000_bib8","unstructured":"World Bank\n          . Nigeria Poverty and Equity Brief: October 2024 (English). Accessed 16 October 2025. http:\/\/documents.worldbank.org\/curated\/en\/099108001062551445."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/6\/1964\/2508485\/blooda_adv-2025-018364-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/6\/1964\/2508485\/blooda_adv-2025-018364-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:06:58Z","timestamp":1774030018000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/6\/1964\/565993\/Initial-low-and-moderate-dose-of-hydroxyurea-has-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,3,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018364","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,24]]},"published":{"date-parts":[[2026,3,13]]}}}